Implantable biochip for managing trauma--induced hemorrhage

• US 20120088997A1
• Filed: 10/12/2011
• Published: 04/12/2012
• Est. Priority Date: 10/12/2010
• Status: Abandoned Application

• Current Assignee: Anthony Guiseppi-Elie
• Original Assignee: Anthony Guiseppi-Elie
• Inventors: Guiseppi-Elie, Anthony
• Application Number:
  US13/317,236
• Publication Number:
  US 20120088997A1
• Time in Patent Office: Days
• US Class Current: 600/364
• CPC Class Codes: A61B 5/145 Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissuemeasuring of blood pressure or blood flow A61B5/02; non-radiation detecting or locating of foreign bodies in blood A61B5/06
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14539 for measuring pH
• CPC Class Codes: A61B 5/14542 for measuring blood gases A61B5/14551 takes precedence

Abstract

A biocompatible biosensor and transmitter device for temporary implantation prior to, during and following trauma-induced hemorrhaging detects the presence and level of at least one analyte and transmits detected data to a second, external device. Thus, a method for managing post-trauma patient outcomes includes providing such a biosensor and transmitter device, temporarily implanting the biocompatible biosensor and transmitter device intramuscularly in a trauma victim; and monitoring the presence and level of the at least one analyte detected by the biocompatible biosensor and transmitter device and transmitted to the external data receiving means.

Claims

1. An analyte measuring device for monitoring physiological status by measuring at least one analyte, comprising:

an insulating substrate;

a conductive material supported on the insulating substrate;

an insulating layer overlying the conductive material, the insulating layer formed in a pattern thereby passivating covered surface portions of the underlying conductive material and exposing predetermined surface portions of the conductive material, the exposed portions of the conductive material functioning as electrodes;

a polymeric biorecognition layer immediately adjacent to the insulating layer and the exposed surface portions of the conductive material, the polymeric biorecognition layer containing at least one molecular entity of biological or biomimetic origin that is specific to the at least one analyte being measured.

2. The device of claim 1 wherein the physiological status monitored comprises post-trauma status.

3. The device of claim 1 wherein the insulating substrate is selected from dielectric materials comprising polished borosilicate glass, oxidized silicon, alumina, polyamide, and silicone.

4. The device of claim 1 wherein the conductor is selected from the group comprising gold, platinum, palladium, iridium, indium tin oxide, polyaniline, polypyrrole and polythiophene.

5. The device of claim 1 wherein the insulating layer is selected from dielectric materials comprising silicon nitride, silicon oxide, spin-on-glass, and polyimide.

6. The device of claim 1 wherein the polymeric recognition layer comprises a hydrated hydrogel.

7. The device of claim 1 wherein the molecular entity of biological or biomimetic origin comprises a member selected from the group comprising DNA, RNA, enzymes, antibodies, antibody fragments, and antibody-linked enzymes, and wherein the molecular entity of biological or biomimetic origin is covalently attached to the polymer of the polymeric biorecognition layer.

8. The device of claim 7 wherein the molecular entity of biological or biomimetic origin comprises an enzyme, the enzyme being chemically modified by the covalent attachment of methacryloyl groups.

9. The device of claim 8 wherein the enzyme is selected from lactate oxidase, glucose oxidase, and laccase.

10. A biocompatible biosensor and transmitter device for temporary implantation prior to, during and following trauma-induced hemorrhaging, the device detecting the presence and level of at least one analyte and transmitting detected data to a second, external data receiving device.

11. The biocompatible biosensor and transmitter device set forth in claim 10 wherein the at least one analyte comprises lactate.

12. The biocompatible biosensor and transmitter device set forth in claim 11 wherein the at least one analyte comprises glucose.

13. The biocompatible biosensor and transmitter device set forth in claim 11 wherein the at least one analyte comprises oxygen.

14. The biocompatible biosensor and transmitter device set forth in claim 11 wherein the at least one analyte comprises H⁺ cations for detecting pH.

15. A method for managing post-trauma patient outcomes comprising:

providing a biocompatible biosensor and transmitter device and a data receiving means, the biocompatible biosensor and transmitter device capable of detecting the presence and level of at least one analyte and transmitting detected data to the data receiving means;

temporarily implanting the biocompatible biosensor and transmitter device into a muscle of a hemorrhaging trauma victim; and

employing the biosensor of the biocompatible device to collect data regarding the presence or the amount of the at least one analyte and employing the transmitter of the biocompatible device to transmit data to the data receiving means.

16. The method set forth in claim 15 wherein the data receiving means is programmed for processing and presenting the received data.